Clinical Outcomes Following Coronary Bifurcation PCI Techniques: A Systematic Review and Network Meta-Analysis Comprising 5,711 Patients.


Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
22 06 2020
Historique:
received: 04 02 2020
revised: 25 03 2020
accepted: 31 03 2020
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 15 12 2020
Statut: ppublish

Résumé

The aim of this study was to compare clinical outcomes of different bifurcation percutaneous coronary intervention (PCI) techniques. Despite several randomized trials, the optimal PCI technique for bifurcation lesions remains a matter of debate. Provisional stenting has been recommended as the default technique for most bifurcation lesions. Emerging data support double-kissing crush (DK-crush) as a 2-stent technique. PubMed and Scopus were searched for randomized controlled trials comparing PCI bifurcation techniques for coronary bifurcation lesions. Outcomes of interest were major adverse cardiovascular events (MACE). Secondary outcomes of interest were cardiac death, myocardial infarction, target vessel or lesion revascularization, and stent thrombosis. Summary odds ratios (ORs) were estimated using Bayesian network meta-analysis. Twenty-one randomized controlled trials including 5,711 patients treated using 5 bifurcation PCI techniques were included. Investigated techniques were provisional stenting, T stenting/T and protrusion, crush, culotte, and DK-crush. Median follow-up duration was 12 months (interquartile range: 9 to 36 months). When all techniques were considered, patients treated using the DK-crush technique had less occurrence of MACE (OR: 0.39; 95% credible interval: 0.26 to 0.55) compared with those treated using provisional stenting, driven by a reduction in target lesion revascularization (OR: 0.36; 95% credible interval: 0.22 to 0.57). No differences were found in cardiac death, myocardial infarction, or stent thrombosis among analyzed PCI techniques. No differences in MACE were observed among provisional stenting, culotte, T stenting/T and protrusion, and crush. In non-left main bifurcations, DK-crush reduced MACE (OR: 0.42; 95% credible interval: 0.24 to 0.66). In this network meta-analysis, DK-crush was associated with fewer MACE, driven by lower rates of repeat revascularization, whereas no significant differences among techniques were observed for cardiac death, myocardial infarction, and stent thrombosis. A clinical benefit of 2-stent techniques was observed over provisional stenting in bifurcation with side branch lesion length ≥10 mm.

Sections du résumé

OBJECTIVES
The aim of this study was to compare clinical outcomes of different bifurcation percutaneous coronary intervention (PCI) techniques.
BACKGROUND
Despite several randomized trials, the optimal PCI technique for bifurcation lesions remains a matter of debate. Provisional stenting has been recommended as the default technique for most bifurcation lesions. Emerging data support double-kissing crush (DK-crush) as a 2-stent technique.
METHODS
PubMed and Scopus were searched for randomized controlled trials comparing PCI bifurcation techniques for coronary bifurcation lesions. Outcomes of interest were major adverse cardiovascular events (MACE). Secondary outcomes of interest were cardiac death, myocardial infarction, target vessel or lesion revascularization, and stent thrombosis. Summary odds ratios (ORs) were estimated using Bayesian network meta-analysis.
RESULTS
Twenty-one randomized controlled trials including 5,711 patients treated using 5 bifurcation PCI techniques were included. Investigated techniques were provisional stenting, T stenting/T and protrusion, crush, culotte, and DK-crush. Median follow-up duration was 12 months (interquartile range: 9 to 36 months). When all techniques were considered, patients treated using the DK-crush technique had less occurrence of MACE (OR: 0.39; 95% credible interval: 0.26 to 0.55) compared with those treated using provisional stenting, driven by a reduction in target lesion revascularization (OR: 0.36; 95% credible interval: 0.22 to 0.57). No differences were found in cardiac death, myocardial infarction, or stent thrombosis among analyzed PCI techniques. No differences in MACE were observed among provisional stenting, culotte, T stenting/T and protrusion, and crush. In non-left main bifurcations, DK-crush reduced MACE (OR: 0.42; 95% credible interval: 0.24 to 0.66).
CONCLUSIONS
In this network meta-analysis, DK-crush was associated with fewer MACE, driven by lower rates of repeat revascularization, whereas no significant differences among techniques were observed for cardiac death, myocardial infarction, and stent thrombosis. A clinical benefit of 2-stent techniques was observed over provisional stenting in bifurcation with side branch lesion length ≥10 mm.

Identifiants

pubmed: 32553331
pii: S1936-8798(20)30929-8
doi: 10.1016/j.jcin.2020.03.054
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1432-1444

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Giuseppe Di Gioia (G)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; Department of Advance Biomedical Sciences, Federico II University, Naples, Italy.

Jeroen Sonck (J)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; Department of Advance Biomedical Sciences, Federico II University, Naples, Italy.

Miroslaw Ferenc (M)

Division of Cardiology and Angiology II, University Heart Centre Freiburg, Bad Krozingen, Bad Krozingen, Germany.

Shao-Liang Chen (SL)

Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China; Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.

Iginio Colaiori (I)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Emanuele Gallinoro (E)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Takuya Mizukami (T)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; Division of Cardiology, Showa University Fujigaoka Hospital, Kanagawa, Japan.

Monika Kodeboina (M)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; Department of Advance Biomedical Sciences, Federico II University, Naples, Italy.

Sakura Nagumo (S)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium; Division of Cardiology, Showa University Fujigaoka Hospital, Kanagawa, Japan.

Danilo Franco (D)

Department of Advance Biomedical Sciences, Federico II University, Naples, Italy.

Jozef Bartunek (J)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Marc Vanderheyden (M)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Eric Wyffels (E)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Bernard De Bruyne (B)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Jens F Lassen (JF)

Department of Cardiology, Odense University Hospital & University of Southern Denmark, Odense, Denmark.

Johan Bennett (J)

Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.

Dobrin Vassilev (D)

"Alexandrovska" University Hospital, Sofia, Bulgaria.

Patrick W Serruys (PW)

Department of Cardiology, National University of Ireland, Galway, Ireland.

Goran Stankovic (G)

Department for Diagnostic and Catheterization Laboratories, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Yves Louvard (Y)

Department of Cardiology, Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Hopital Privé Jacques Cartier, Massy, France.

Emanuele Barbato (E)

Department of Advance Biomedical Sciences, Federico II University, Naples, Italy.

Carlos Collet (C)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium. Electronic address: carloscollet@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH